Imidazolidine-based metal carbene metathesis catalysts
    3.
    发明授权
    Imidazolidine-based metal carbene metathesis catalysts 有权
    咪唑烷系金属卡宾复分解催化剂

    公开(公告)号:US08846939B2

    公开(公告)日:2014-09-30

    申请号:US13494708

    申请日:2012-06-12

    IPC分类号: C07F15/00

    摘要: The present invention relates to novel metathesis catalysts with an imidazolidine-based ligand and to methods for making and using the same. The inventive catalysts are wherein: M is ruthenium or osmium; X and X1 are each independently an anionic ligand; L is a neutral electron donor ligand; and, R, R1 R6, R7, R8, and R9 are each independently hydrogen or a substituent selected for the group consisting of C1 C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, aryl, C1-C20 alkoxycarbonyl, C1-C20 alkyithiol, aryl thiol, C1-C20 alkylsulfortyl and C1-C20 alkylsulfinyl, the substituent optionally substituted with one or more moieties selected from the group consisting of C1-C20 alkyl, C1-C10 alkoxy, aryl, and a functional group. The inclusion of an imidazolidine ligand to the previously described ruthenium or osmium catalysts has been found to dramatically improve the properties of these complexes.

    摘要翻译: 本发明涉及具有咪唑烷类配体的新型复分解催化剂及其制备和使用方法。 本发明的催化剂是其中:M是钌或锇; X和X1各自独立地为阴离子配体; L是中性电子给体配体; 并且,R 1,R 1,R 6,R 7,R 8和R 9各自独立地为氢或选自由C 1 -C 20烷基,C 2 -C 20烯基,C 2 -C 20炔基,芳基,C 1 -C 20烷氧基羰基,C 1 -C 20 烷基硫醇,芳基硫醇,C 1 -C 20烷基磺酰基和C 1 -C 20烷基亚磺酰基,所述取代基任选被一个或多个选自C 1 -C 20烷基,C 1 -C 10烷氧基,芳基和官能团的部分取代。 已经发现将咪唑烷配体包含在前述的钌或锇催化剂中可显着地改善这些络合物的性质。

    Imidazolidine-based metal carbene metathesis catalysts

    公开(公告)号:US07329758B1

    公开(公告)日:2008-02-12

    申请号:US09576370

    申请日:2000-05-22

    IPC分类号: C07F15/00 C07F7/02 C08F4/80

    摘要: The present invention relates to novel metathesis catalysts with an imidazolidine-based ligand and to methods for making and using the same. The inventive catalysts are of the formula wherein: M is ruthenium or osmium; X and X1 are each independently an anionic ligand; L is a neutral electron donor ligand; and, R, R1 R6, R7, R8, and R9 are each independently hydrogen or a substituent selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, aryl, C1-C20 carboxylate, C1-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy, C2-C20 alkoxycarbonyl, C1-C20 alkylthiol, aryl thiol, C1-C20 alkylsulfonyl and C1-C20 alkylsulfinyl, the substituent optionally substituted with one or more moieties selected from the group consisting of C1-C10 alkyl, C1-C10 alkoxy, aryl, and a functional group selected from the group consisting of hydroxyl, thiol, thioether, ketone, aldehyde, ester, ether, amine, imine, amide, nitro, carboxylic acid, disulfide, carbonate, isocyanate, carbodiimide, carboalkoxy, carbamate, and halogen. The inclusion of an imidazolidine ligand to the previously described ruthenium or osmium catalysts has been found to dramatically improve the properties of these complexes. The inventive catalysts maintains the functional group tolerance of previously described ruthenium complexes while having enhanced metathesis activity that compares favorably to prior art tungsten and molybdenum systems.